$0.4494
0.0135[3.10%]
At close: Apr 26
$0.4494
0[0.00%]
After Hours: 5:36PM EDT
Latest News for GRI Bio Stock (NASDAQ:GRI)
GRI Bio Stock (NASDAQ: GRI)
Categories: All
Tuesday, April 16, 2024
Monday, April 08, 2024
Thursday, April 04, 2024
Tuesday, April 02, 2024
Monday, April 01, 2024
Thursday, March 14, 2024
Monday, March 04, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
Wednesday, February 07, 2024
Tuesday, February 06, 2024
Friday, February 02, 2024
- S&P 500 Gains Over 1%; Amazon Earnings Top ExpectationsAvi Kapoor - Feb 2, 2024, 2:32PM
- Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Feb 2, 2024, 1:18PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Feb 2, 2024, 12:31PM
- GRI Bio shares are trading lower after the company announced pricing of a $5.5 million public offering.Benzinga Newsdesk - Feb 2, 2024, 12:26PM
- Nasdaq Rises Over 200 Points; Apple Posts Upbeat EarningsAvi Kapoor - Feb 2, 2024, 12:08PM
- Dow Falls 150 Points; US Economy Adds 353,000 Jobs In JanuaryAvi Kapoor - Feb 2, 2024, 9:48AM
- Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Feb 2, 2024, 8:21AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Feb 2, 2024, 8:06AM
- GRI Bio Announces Pricing Of Reasonable Best Efforts Public Offering With Participation From Institutional Investors; 5M Shares At $1.10Benzinga Newsdesk - Feb 2, 2024, 8:04AM
Thursday, February 01, 2024
Wednesday, January 31, 2024
Tuesday, January 30, 2024
Monday, January 29, 2024
Friday, January 26, 2024
Tuesday, January 16, 2024
Friday, December 22, 2023
Tuesday, December 05, 2023
- Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Dec 5, 2023, 1:06PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Dec 5, 2023, 12:31PM
- GRI Bio shares are trading lower. The company announced the initiation of patient enrollment in the Phase 2a biomarker study evaluating GRI-0621 for the treatment of IPF.Benzinga Newsdesk - Dec 5, 2023, 11:49AM
- GRI Bio Commences Patient Enrollment In Phase 2a Biomarker Study Evaluating Lead Program GRI-0621 For The Treatment Of Idiopathic Pulmonary FibrosisBenzinga Newsdesk - Dec 5, 2023, 9:07AM
- Why GitLab Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving PremarketLisa Levin - Dec 5, 2023, 9:04AM
Friday, December 01, 2023
Monday, November 27, 2023
Thursday, November 23, 2023
Wednesday, November 15, 2023
Tuesday, October 31, 2023
Wednesday, October 25, 2023
Tuesday, October 24, 2023
Monday, October 23, 2023
Friday, October 20, 2023
Thursday, October 19, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Oct 19, 2023, 5:31PM
- GRI Bio Presents Translational Data Demonstrating Connection Between NKT Cells And The Pathogenesis Of Idiopathic Pulmonary Fibrosis At The 2023 Pittsburgh-Ireland International Lung ConferenceBenzinga Newsdesk - Oct 19, 2023, 8:50AM